GE-commissioned survey blasts neurological disease Dx delays

A survey commissioned by GE Healthcare ($GE) is critical of how patients with Alzheimer's, Parkinson's and multiple sclerosis are diagnosed. The conclusion: It took 7 to 12 months on average to form definitive diagnoses after the first onset of symptoms. Both physicians and patients took part in the survey. Physicians said about a third of patients could have been diagnosed sooner. The criticism is that delays in diagnosing the neurodegenerative conditions lead to either wrong or unnecessary treatments, creating added costs and anxiety. GE is developing imaging agents and other equipment focused, in part, on neurological disorders. Item

Suggested Articles

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.

The FDA has announced a series of actions aimed at limiting the use of power morcellators in gynecologic surgeries.

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.